Hemoglobin Oxygen Therapeutics Headquarters
Looking for information about Hemoglobin Oxygen Therapeutics Headquarters? The links below have collected all the necessary data.
HbO2 Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/hbo2-therapeutics
- Headquarters Regions Greater Philadelphia Area, Great Lakes, Northeastern US; Founded Date 2014; Founders Jerry Kowalski, Zaf Zafirelis; Operating Status Active; Last Funding Type Seed; Also Known As Hemoglobin Oxygen Therapeutics; Legal Name Hemoglobin Oxygen Therapeutics LLC; Company Type For Profit; Contact Email [email protected]: 2014
Hemoglobin Oxygen Therapeutics LLC - Company Profile and ...
- https://www.bloomberg.com/profile/company/1456313D:US
- Hemoglobin Oxygen Therapeutics LLC. Hemoglobin Oxygen Therapeutics LLC was founded in 2014. The company's line of business includes the construction of industrial buildings and …
Hemoglobin Oxygen Therapeutics LLC LinkedIn
- https://www.linkedin.com/company/hemoglobin-oxygen-therapeutics-llc
- Hemoglobin Oxygen Therapeutics LLC is a pharmaceuticals company based out of 674 Souder Road, Souderton, Pennsylvania, United States.
HbO2 Therapeutics LinkedIn
- https://www.linkedin.com/company/hbo2-therapeutics
- HbO2 Therapeutics 78 followers on LinkedIn. We offer a solution when blood transfusion is not an option. Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and ...Founded: 2014
HbO2 Therapeutics Company Profile: Valuation & Investors ...
- https://pitchbook.com/profiles/company/110097-37
- Mar 13, 2015 · HbO2 Therapeutics General Information Description. Developer of hemoglobin based technologies. The company provides intravenous oxygen-delivery support to help stabilize the patient and prevent tissue damage or organ dysfunction associated with oxygen deprivation.
Regulatory Framework for Hemoglobin-Based Oxygen Carrier ...
- https://link.springer.com/chapter/10.1007/978-3-642-40717-8_9
- Dec 19, 2013 · Abstract. Oxygen therapeutics (OT) consist of hemoglobin-based oxygen carriers (HBOCs) and fluorocarbons. They have been developed to deliver oxygen (O 2) to tissues, mainly for treatment of shock due to blood loss. These products are being developed in order to treat blood loss when red blood cells are not available, as may occur on the battlefield or in civilian life when trauma …
NIH/FDA/DOD Interagency Working Group on Oxygen Therapeutics
- https://link.springer.com/chapter/10.1007%2F978-3-642-40717-8_8
- Dec 19, 2013 · Cite this chapter as: Mitchell P., Weiskopf R., Zapol W.M. (2013) NIH/FDA/DOD Interagency Working Group on Oxygen Therapeutics. In: Kim H., Greenburg A. (eds) Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics.
Artificial Oxygen Carriers (Hemoglobin-Vesicles) as a ...
- https://link.springer.com/chapter/10.1007/978-3-642-21729-6_206
- Hemoglobin-vesicles (HbV) are artificial oxygen carriers that mimic the cellular structure of RBCs to replace the blood transfusion. One injection of HbV in place of a blood transfusion is estimated as equivalent to a massive dose, such as several hundred milliliters or a few liters of normal blood contents.
Have you found Hemoglobin Oxygen Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.